Mesoblast Ltd (MESO) Price Targets From Analysts
Use the tables below to see what analysts covering Mesoblast Ltd think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
Over the past 94 days, MESO's average price target has gone down $1.33.
Over the past 168 days, MESO's average upside potential has been 32.29%.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
MESO Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- Mesoblast Ltd's variance in analysts' estimates is lower than 3.34999999999999% of all US stocks.
- MESO has a greater upside potential (average analyst target price relative to current price) than 97.2% of stocks in the mid market cap category.
- The number of analysts covering the stock of MESO is higher than 80.82% of Pharmaceutical Products stocks.
- MESO has a higher average analyst price target than 21.28% of stocks in the mid market cap category.
What is the outlook for MESO? Use POWR Ratings for clearer insight into price direction.